News

Royan Stem Cell Technology Company (RSCT), having cryopreserved more than 220,000 cord blood stem cells, launched various clinical trials on various terminal and/or chronic diseases in full success taking advantage of cord blood stem cells, run its refinery plant of maternity products ending to manufacturing some biological products and sought a healthy nation as one of the main pillars of sustainable and prosperous nation, celebrates its 21rd year of existence, providing its services both nationwide and worldwide.

Enjoying a team of experts, researchers and scientists of various expertise and skills, Royan Stem Cell Technology Company (RSCT) has been providing its services to all its countrymen seeking for remedies to relive their pains or future hopes. On the occasion of its 21rd anniversary of existence, Royan Stem Cell Technology Company (RSCT) is committed to follow its responsibilities it has already adopted to, so that it can portrait a hopeful horizon for all the patients all around the world via the network it has already set up with its counterparts of common interests.